MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
18.17
+0.27 (1.51%)
Jun 8, 2026, 10:29 AM EDT - Market open
MLTX Market Cap
MLTX has a market cap or net worth of $1.34 billion as of June 8, 2026. Its market cap has decreased by -45.32% in one year.
Market Cap
1.34B
Enterprise Value
1.06B
1-Year Change
-45.32%
Ranking
Category
Stock Price
$18.17
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.34B, an increase of 37,075.16%. That is a compound annual growth rate of 295.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 1.32B | 40.08% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ardelyx | 1.37B |
| Maze Therapeutics | 1.34B |
| Bicara Therapeutics | 1.31B |
| Immatics | 1.31B |
| UroGen Pharma | 1.31B |
| Maravai LifeSciences Holdings | 1.30B |
| Damora Therapeutics | 1.29B |
| Savara | 1.29B |